Dr. Reddy’s Q3 net profit surges 77% to ₹1,247 crore
Total revenue from operations increased by 27% to 6770 crore, compared to 5319.7 crore in the previous quarter.
Dr. Reddy Laboratories
Stay updated with the latest news and articles about Dr. Reddy Laboratories.
Latest Articles
Stocks to watch: Vedanta, Maruti Suzuki, Hero MotoCorp, IOC, Tata Power and others
When they release their September quarter profits today, Bharti Airtel, Tata Steel, L&T, Castrol India, and Aashi India Glass will be in the spotlight.
Dr. Reddy’s Q2 performance consolidated PAT rises 12% year-over-year at Rs 1,113 crore
In comparison to 53.4% in Q2FY22 and 49.9% in Q1FY23, its gross margin increased to 59.1% in Q2FY23. In the most recent quarter, EBITDA totaled Rs.1,932 crore, or 30.6% of total revenues.